Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesIntraocular Pressure Reduction by Latanoprost in Japanese Normal Tension Glaucoma Patients Over a Five-Year Period Stratified by Presenting IOP
Journal of Ocular Pharmacology and Therapeutics, 11/04/09
Tsuda M et al. – Latanoprost administration was effective in reducing IOP over a 5–year period in a range of 3.1–4.1 and 1.3–3.6 mmHg in NTG patients with high– and low–tension levels, respectively. In addition, these results indicate that latanoprost helped to prevent a decrease in MD values in both groups, as shown by the results of HFA examinations.
Related Articles
Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09
Relevance Score: 93%
Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09
Relevance Score: 92%
Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09
Relevance Score: 91%
Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09
Relevance Score: 91%
Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09
Relevance Score: 91%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09
Retinal Arteriolar Vascular Reactivity in Untreated and Progressive Primary Open Angle Glaucoma
Investigative Ophthalmology and Visual Science, 11/20/09
"Treat and Extend" Dosing of Intravitreal Antivascular Endothelial Growth Factor Therapy for Type 3 Neovascularization/Retinal Angiomatous Proliferation
Retina, 11/20/09
Today in Glaucoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Optic Disc Diameter Increases During Acute Elevations of Intraocular Pressure
Investigative Ophthalmology and Visual Science, 11/24/09
Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
Clinical Ophthalmology, 11/23/09
The biomechanics of glaucoma
Eye World, 11/23/09
Article Search
Sponsor